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ABSTRACT Neuroserpin is a member of the serine proteinase inhibitor superfamily. It can undergo a conformational transition
to form polymers that are associated with the dementia familial encephalopathy with neuroserpin inclusion bodies and the wild-
type protein can inhibit the toxicity of amyloid-b peptides in Alzheimer’s disease. We have used a single molecule ﬂuorescence
method, two color coincidence detection, to determine the rate-limiting steps of the early stages of the polymerization of ﬂuoro-
phore-labeled neuroserpin and have assessed how this process is altered in the presence of Ab1–40. Our data show that neuro-
serpin polymerization proceeds ﬁrst by the unimolecular formation of an active monomer, followed by competing processes of
both polymerization and formation of a latent monomer from the activated species. These data are not in keeping with the
recently proposed domain swap model of polymer formation in which the latent species and activated monomer are likely to
be formed by competing pathways directly from the unactivated monomeric serpin. Moreover, the Ab1–40 peptide forms
a weak complex with neuroserpin (dissociation constant of 10 5 5 nM) that increases the amount of active monomer thereby
increasing the rate of polymerization. The Ab1–40 is displaced from the complex so that it acts as a catalyst and is not incorporated
into neuroserpin polymers.
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Alzheimer’s disease is one of the most common forms of
dementia. The pathological features are characterized by
neurofibrillary tangles and extracellular plaques that are
formed from fragments of the amyloid precursor protein
(APP). These plaques are composed of the 42 (Ab1–42)
and, to a lesser extent, 40 (Ab1–40) amino acid peptides
(1). There is now increasing recognition that it is not the pla-
ques, but rather the soluble oligomers of amyloid-b that are
the neurotoxic species in Alzheimer’s disease. Ancillary
proteins, such as neuroserpin, may bind to these peptides
and reduce their toxic effect. Indeed neuroserpin has been
demonstrated histologically to colocalize with Ab plaques
in Alzheimer’s patients, to form a 1:1 interaction with
Ab1–42, and to alter the appearance of the aggregates, making
them spherical rather than fibrillar (2). Moreover neuroserpin
reduces the toxicity of the Ab1–42 peptide in both cell and fly
models of disease (2).
Neuroserpin is a 45 kDa member of the serine protease
inhibitor or serpin superfamily (3–5). It is expressed during
the late stage of development in neurons of the central and
peripheral nervous system and in the adult brain (6,7). The
target proteinase of neuroserpin is tissue plasminogen acti-
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0006-3495/09/10/2306/10 $2.00vator (tPA) (8), which is expressed at low levels within the
central nervous system and is thought to play a role in the
development of synaptic plasticity and in learning and
memory (9). Point mutations in the neuroserpin gene
underlie an autosomal dominant dementia called familial
encephalopathy with neuroserpin inclusion bodies (FENIB)
(10–12). This disease is characterized by the retention of
ordered polymers of neuroserpin as periodic acid-Schiff
positive Collin’s bodies within the endoplasmic reticulum
of neurons (10–13). Five unique disease causing mutations
within the neuroserpin gene have been identified in six
families with FENIB (11,14). These families show a clear
correlation between genotype and phenotype that can be
explained by the rate of neuroserpin polymerization (8,
11–13,15). Those mutants that polymerize most rapidly
in vitro are associated with the greatest number of cerebral
inclusions in vivo and the earliest age of disease onset.
Previous work has shown that serpin polymers, such as those
of mutant neuroserpin associated with FENIB, result from
the sequential linkage between the reactive center loop of
one molecule and b-sheet A of another (4,8,15). However
this has been challenged recently by the crystal structure
of a closed dimer of another serpin, antithrombin, which
showed a remarkable domain swap containing not only the
reactive center loop but also strand 5A (16). Therefore it is
of great interest to probe both the details of neuroserpin
polymerization and also its interaction with Ab peptides.
The analysis of individual molecules has been shown to
be a powerful tool to study biological processes because it
allows dynamic processes to be followed and to show hetero-
geneities hidden in bulk averaging. We have recently
doi: 10.1016/j.bpj.2009.07.057
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the excitation of two distinct fluorophores with two lasers
and used this to sensitively detect and identify associated
molecules and oligomers, which give rise to coincident
bursts of two colors of fluorescence. Our method, called
two color coincidence detection (TCCD), has been used to
measure the stoichiometry of human telomerase enzyme
(17), the association of proteins on the surface of a live
T-cell (18) and to follow the oligomerization of the SH3
domain before and during fibril formation (19). In this study,
we have exploited the sensitivity of TCCD to follow protein
aggregation. We first study the initial stages of the polymer-
ization of fluorophore-labeled neuroserpin and then deter-
mine how this is altered in the presence of Ab. Our results
provide what we believe to be new insights into both the
polymerization of neuroserpin and its interaction with the
Ab peptide.
MATERIALS AND METHODS
Expression and puriﬁcation
The Ser229Cys mutation was introduced into the cDNA of wild-type neuroser-
pin containing a 6-His N-terminal-tag in the pQE81L vector by site directed
mutagenesis. Wild-type and Ser229Cys neuroserpin were then expressed in
Escherichia coli and purified to homogeneity as detailed previously (8).
Labeling of Ser229Cys neuroserpin
with Alexa 488 or Alexa 647
Neuroserpin was incubated for 30–60 min at room temperature at a concen-
tration of 0.5–1 mg in the presence of 0.1 M DTT. The DTT was then
removed by filtration through a NAP-10 column (Amersham Biosciences,
Little Chalfont, UK) and the protein treated with 10–20-fold molar excess
of either Alexa 488 or Alexa 647 in a final concentration of 5% v/v
DMSO. The mixture was incubated for 2 h at room temperature and then
overnight at 4C before being centrifuged at 16,000  g for 20 min. The
supernatant was loaded onto a HisTrap Column in 20 mM imidazole, 20
mM Na2PO4, and 20 mM NaCl (pH 7.8) and bound neuroserpin was batch
eluted with 300 mM imidazole, 20 mM sodium phosphate, and 20 mM NaCl
(pH 7.8). The eluent was gel filtered into PBS with a NAP-10 column and
the labeling efficiency was determined by comparing protein absorption at
280 nm with the absorption of Alexa 488 at 488 nm and Alexa 647 at
647 nm. Labeling efficiency was calculated using the formula
% labeled protein ¼ 100 Absprobe
Absprotein
 MMprotein
EC
; (1)
where Abs is the absorbance in OD, MM is the molecular mass in Da, and EC
is the extinction coefficient in cm1M1. The EC values used for Alexa 488
and Alexa 647 were 71,000 and 239,000, respectively. The final optimized
strategy yielded labeling efficiencies of nearly 100% for Alexa 488-neuro-
serpin and 40% for Alexa 647-neuroserpin.
Polymerization of neuroserpin
Stock solutions of Alexa 488- and Alexa 647-labeled neuroserpin monomers
were stored at 80C. They were thawed at room temperature and then
centrifuged at 13.2 kRPM for 30 min to remove any aggregates. Equimolar
mixtures of Alexa 488- and Alexa 647-labeled monomeric neuroserpin were
incubated in PBS at 45C at total neuroserpin concentrations ranging from
0.1 mg/mL (2.2 mM) to 0.3 mg/ml (6.6 mM). Aliquots were taken at time-points up to 480 min, snap-frozen in liquid nitrogen, and stored at 80C
until measurement by TCCD.
The interaction between neuroserpin and Ab1–40
The effect of Ab1–40 on the polymerization of neuroserpin was determined
by adding increasing concentrations of unlabeled Ab1–40 (Bachem, Buben-
dorf, Switzerland) in 20 mL of PBS at the start or after 30 min of a polymer-
ization reaction containing 0.1 mg/mL total neuroserpin (equimolar mixture
of Alexa 488- and Alexa 647-neuroserpin). The direct interaction between
Ab1–40 and neuroserpin was assessed with equimolar concentrations of
HiLyte Fluor 488 N-terminal labeled Ab1–40 (AnaSpec, Fremont, CA) and
Alexa 647-Nsp. The solutions were incubated at 45C or preincubated for
24 h at 37C before raising the temperature to 45C.
TCCD measurements
Snap-frozen aliquots of the incubated sample were thawed at room tempera-
ture and diluted in PBS to a measurement concentration of ~50 pM. Control
experiments with and without snap freezing showed that freezing had no effect
on the single molecule fluorescence data (data not shown). Typically, 200 mL
of sample solution were analyzed on glass coverslips that had been precoated
with a 1 mg/mL solution of bovine serum albumin for at least 1 h before
measurement to minimize sample adsorption. Data acquisition typically lasted
80 min. For certain timepoints, longer acquisition times were used to recover
larger numbers of events to obtain histograms with better statistics. For these,
1 mL of sample solution was placed in chambered cover glasses that had
been similarly precoated with bovine serum albumin and measured for 16 h
each. The instrumentation for TCCD measurement has been reported in detail
previously (20,21). Briefly, two overlapped Gaussian laser beams, at 488 nm
(Spectra Physics Cyan CDRH, Mountain View, CA) and 633 nm (He/Ne
laser, 25LHP151, Melles Griot, Albuquerque, NM), were directed to the
back port of an inverted microscope (Nikon Eclipse TE2000-U, Tokyo,
Japan). The beams were focused 6mm into the sample through an Apochromat
60, NA 1.40 oil immersion objective (Nikon). Fluorescence was collected
by the same objective and imaged onto a 50 mm pinhole (Melles Griot),
then separated into two different channels using a dichroic mirror
(585DRLP Omega Filters, Brattleboro, VT) and sent to two avalanche photo-
diodes (SPCM AQR-14, PerkinElmer Optoelectronics, Quebec, Canada). The
cross talk (detection of one fluorophore emission in the other channel) from the
blue channel to the red channel was 1% whereas the cross talk from the red
channel to blue channel was negligible. All measurements used laser powers
of 220 mW and 60 mW for the blue and red channels, respectively. For all the
single molecule experiments, data were collected at 20C with a 1 ms bin time
on both multi channel scalar cards, and burst selection was carried out by
applying suitable threshold values (22). From TCCD measurements the asso-
ciation quotientQ is obtained. This parameter is proportional to the fraction of
dual-labeled molecules in a heterogeneous mixture (21), and is defined as
Q ¼ rS
rB þ rR  rS; (2)
where rB and rR are the fluorescence burst rates in the 488 and 647 channel
respectively; the burst rate of significant coincident events, rS, is obtained by
subtracting the rate of coincident events due to chance, rE, from the total
coincident events rate rC. Coincidence histograms of the function Z, defined
as ln(IR/IB), are built up from the significant coincident bursts, after
removing the contribution of chance coincidence (21).
Kinetic model of polymerization
Possible kinetic models and kinetic rate constants underlying neuroserpin
polymerization were studied by means of a global fitting procedure of
both experimentally derived Q time traces and the intensity ratio histograms
obtained at three different incubation times. The procedure was to numeri-
cally solve the differential equations defining the kinetic model, simulate
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rate constants to adjust the simulations to the experimental data by the least-
squares method. Several different kinetic models were tested by generating
differential kinetic equations for monomers and higher order species.
A detailed description of the kinetic models, the solution of the differential
equations, the simulations of TCCD measurement outputs, the association
quotient and coincidence histograms, and the fitting protocol can be found
in the Supporting Material.
RESULTS AND DISCUSSION
Characterization of ﬂuorophore-labeled
neuroserpin
To carry out single-molecule fluorescence experiments,
a single cysteine mutation (Ser229Cys) was introduced into
the neuroserpin (Nsp) gene, which contains no natural cyste-
ines. This residue was chosen as the homologous residue in
antitrypsin (232Cys) can be labeled with large fluorophores
without affecting polymerization (23,24). In agreement
with this, we found that recombinant Ser229Cys neuroserpin
had a normal far UV CD profile, formed SDS-stable
complexes with tPA (Fig. 1; ka ¼ 3.7 (5 0.1) 104 M1s1;
n ¼ 3) and polymerized at a similar rate to wild-type neuro-
serpin (data not shown). However, the introduction of the
cysteine residue allowed site specific labeling with either
an Alexa Fluor 488 or Alexa Fluor 647 fluorophore as
described in Materials and Methods. The presence of these
fluorophores did not affect either complex formation with
tPA or polymerization (Fig. 1 B). The lowest band in
Fig. 1 B corresponds to monomers. The band above it corre-
sponds to dimers and contains neuroserpin that has formed
cysteine disulfide bonds in the course of the labeling reac-
tion, which we were able to minimize but not remove
completely. These molecules are unlabeled and hence donot affect the single molecule measurements. Polymer
formation is associated with the appearance of discrete,
higher-molecular mass bands corresponding to neuroserpin
oligomers.
Single-molecule study of neuroserpin
polymerization
TCCD is sensitive to very small populations of dimers,
trimers and other oligomers, allowing us to study the early
stages of polymerization. Equimolar mixtures of Alexa Fluor
488- and Alexa Fluor 647-labeled neuroserpin were incu-
bated at 45C and aliquots were taken from the mixture at
different times and snap frozen to stop the reaction and hence
to follow the kinetics of polymerization. These aliquots were
diluted to typical single molecule concentrations (~50 pM)
and measured using TCCD to quantify the fraction of mole-
cules that are associated. The neuroserpin polymers are
known to be highly stable once formed with a melting
temperature >100C so there is no possibility of dissociation
on dilution (25). We measured the association quotient, Q,
which is proportional to the fraction of molecules with at
least one label of each color. Three independent incubations
were carried out at 45C using equimolar amounts of blue-
and red-labeled monomers with a total neuroserpin concen-
tration at 0.1 mg/ml (2.2 mM) to ensure the kinetics were
reproducible. We observed a rapid increase in Q during the
first 2 h before gradually reaching a plateau (Fig. 2 A). The
overall curve fits well to the exponential decay function:
QðtÞ ¼ y0 þ A expðt=tÞ; (3)
where A is a normalization constant (with A < 0), y0 is the
plateau region and t is the rise time. The resulting growth
curves, from independent experiments at the same totalFIGURE 1 Characterization of Ser229Cys neuroserpin.
(A) Purified Ser229Cys neuroserpin was labeled with Alexa
Fluor 647 and assessed by 7.5–15% w/v nondenaturing
PAGE (upper panel); 229 represents labeled Ser229Cys
neuroserpin and wt is the wild-type protein. (Lower panel)
Fluorophore-labeled Ser229Cys formed a complex with tPA
on 7.5–15% w/v/ SDS-PAGE. The protein was visualized
by either Coomassie staining or by fluorescence. (Left to
right): Ser229Cys labeled with Alexa 647, Ser229Cys
labeled with Alexa 647 and addition of tPA, Ser229Cys
labeled with Alexa 647, Ser229Cys labeled with Alexa
647 and addition of tPA, wt neuroserpin, wt neuroserpin
and addition of tPA, tPA, molecular mass standard. (B) A
7.5–15% w/v nondenaturing PAGE to assess the polymer-
ization of Alexa 488- and 647-labeled neuroserpin incu-
bated at 0.1 mg/mL and 45C in PBS buffer pH 7.4.
Each lane represents a different time of incubation (min).
Two micrograms of protein were loaded in each lane. (C)
Polymerization of Ser229Cys neuroserpin labeled with
Alexa 488 and 647 in the presence of different ratios of
Ab1–40 to neuroserpin. Incubation was at 45
C in PBS at
pH 7.4, Ab1–40 was added after 30 min of incubation.
The samples were visualized on 7.5–15% w/v nondenatur-
ing PAGE.
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slightly diverging plateaus. This difference in plateaus is
probably due to the difficulty in accurately controlling the
final concentration of the protein in the incubating mixture
and batch to batch variation in the preparation of labeled neu-
roserpin. The increased noise in the plateau region is due to
the occasional large oligomer entering the probe volume,
events that are not averaged out for each measurement.
Time traces of the average brightness values of coincident
events (corrected for the contribution of chance coincidence,
when two nonassociated molecules enter the probe volume at
the same time) provided a complementary way to observe the
growth of neuroserpin oligomers. Inspection of these traces
(Fig. 2 B) showed a clear increasing trend that is due to the
detected oligomers, initially dimers, growing into higher-
order species involving more than one Alexa 488 or Alexa
647-labeled monomers. The growth continues to increase
whereas the Q curve plateaus, suggesting no additional olig-
omers are formed but those present continue to grow. Using
TCCD we can follow the very early stages of polymerization
where the fraction of polymers is only 1%. The use of an
exponential function fitting allows us to obtain the initial
growth rate as (vQ/vt)t¼0. From measurements in Fig. 2 A
an average value of Q initial growth of 2.25 0.8 106 s1
was obtained.
We then carried out a polymerization reaction again using
0.1 mg/mL neuroserpin, as well as with two higher concentra-
tions, 0.2 and 0.3 mg/mL, all prepared from the same stock
solution, to remove the contribution of batch to batch varia-
tion in the neuroserpin preparation (Fig. 2 C). This experi-
ment showed two noticeable features. First, noting that Q is
proportional to the fraction of all molecules that are associ-
ated, we found that the initial gradient appeared similar for
the three different concentrations (Fig. 2 D), rather than
depending on initial neuroserpin concentration. This suggests
that a unimolecular reaction is rate limiting at the start of the
reaction. The gradient (vQ/vt)t¼0 for 0.3 mg/mL was 2.15
1.5  106 s1 and that for 0.2 mg/mL was 2.4 5 1.1 
106 s1. These are in quantitative agreement with the value
of 2.2 5 0.8  106 s1 found for the 0.1 mg/mL,
as determined within experimental error. To directly recover
the reaction order we plotted ln[(vQ/vt)t¼0] versus ln([M]0)
(see the Supporting Material for details). In this type of anal-
ysis, fitting the data points with a linear regression yields
a slope n 1, where n is equal to the reaction order. We deter-
mined a value for n 1 of0.035 0.12 that clearly indicates
an initial reaction order of 1. This gives the value of the first-
order initial rate kinitial to be (6.4 5 0.6)105 s1 (see the
Supporting Material). The initial first-order behavior strongly
suggests the requirement of a transformation of the monomer
M to an activated form M* responsible for polymer formation
as suggested previously (4,24,26).
The second noticeable feature is that the plateau increases
with increasing concentration of neuroserpin, and that this
plateau does not correspond to a complete polymerization
(Fig. 2 C). In agreement with this feature, the corresponding
gels always show the presence of nonpolymerizing monomer
(Fig. 1). This suggests that there is a competing alternative
path to polymer formation that leads to unreactive monomer.
The plateau of our TCCD curves is concentration dependent,
with a higher polymerization degree reached at higher
concentrations. The data in Fig. 2 C clearly show that
increasing the initial neuroserpin concentration leads to
more neuroserpin being incorporated into polymers and
that this must be due to the increase in the rate of the bimo-
lecular reactions for dimer formation and growth. On the
other hand, the increase in concentration must not accelerate
the reaction giving rise to nonreactive or latent neuroserpin
by the same amount. This suggests that the transformation
to latent form is unimolecular.
FIGURE 2 (A) Association quotient time traces for
labeled Nsp-Alexa 488 and Nsp-Alexa 647 incubation
at a total concentration of 0.1 mg/mL. For incubations 1
and 2 (circles and squares), each data point represents
the average value of three repetitions at the same timepoint.
The last data point for incubation 2 is 240 min. (B) Average
brightness of the coincident events in the blue (squares)
and red (circles) channels from an incubation of labeled
Nsp-Alexa 488 and Nsp-Alexa 647 at a total concentration
of 0.1 mg/mL. The average standard error in the measure-
ments is ~4%. (C) Association quotient time traces for
labeled Nsp-Alexa 488 and Nsp-Alexa 647 incubation at
a total concentration of 0.1 (circles), 0.2 (squares),
and 0.3 mg/ml (triangles) using the same stock of labeled
neuroserpin. The fit to exponential decay functions with
t ¼ 44, 171, and 486 min, respectively are also shown
(lines). (D) Zoom of the early part of C showing the linear
increase in association quotient with time.
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More detailed kinetic modeling of the reaction was under-
taken to globally fit the experimental kinetic traces, and
also the single-molecule coincidence histograms, and hence
find the kinetic scheme that best fitted the data (Figs. 3 and 4).
The fitting procedure we used was based on the global
compartmental analysis approach, a well established meth-
odology to obtain the underlying rate constants on a kinetic
model. This has been applied in several fields, among them
in photophysics (27). We fitted the kinetic Q traces but
also simultaneously the three histograms taken at different
time points that have information on oligomer populations
(from histogram shape), total number of oligomers (from
the total area of the histograms), and how these vary with
time. We also checked the final results gave robust values.
More details of the method and their error analysis can be
found in the Supporting Material. The formation of polymers
can be described by three general kinetic schemes that satisfy
the observations described above. These include a first-order
activation reaction (kA), second order dimer formation (k1),
oligomer propagation through monomer addition (k2) and
polymer-polymer addition (k3), and a first-order transition
to a latent state (kL). This latent state of neuroserpin has
been identified previously and found to be unable to poly-
merize and no longer act as a proteinase inhibitor, however
if this latent monomer is denatured and refolds then function
is restored (25). As TCCD can only detect oligomers and
cannot distinguish between activated monomer or unacti-
vated monomer, it is possible that the activated monomer
converts into unactivated monomer during the single mole-cule measurement. This, however, does not affect our anal-
ysis because the fraction of neuroserpin polymers does not
change during the measurement due to their high stability
and the cessation of the reaction when the sample is snap-
frozen.
Fig. 3 B shows a mechanism in which the formation of
dimers requires that the two monomers are activated to form
M* and that the addition of monomer to the oligomer results
exclusively by the addition of M*. This mechanism provided
a good global fit with the experimental data (c2 ¼ 1.94 
103). Nevertheless, because the formation of dimers requires
two molecules of activated monomer, this reaction needs to be
very fast to explain the appearance of dimers within a few
minutes of the start of the reaction. Indeed, the fit gave a value
for k1 (dimer formation) of 2 105 M1 s1 that is close to the
diffusion limited reaction rate constant for a 45 kDa protein.
Moreover, as the orientation of the molecules is an important
factor in dimer formation (because the loop of one monomer is
inserted into b-sheet A of a second monomer), it seems very
unlikely that such a rapid reaction takes place.
The crystal structure of a stable dimer of another serpin,
antithrombin, led to the proposal that polymer formation
occurs by a domain swap while the protein folds (16). In
this model M* is characterized by an exposed b-hairpin
composed of strands s4A and s5A. Both strands s4A and
s5A must be incorporated into b–sheet A in the latent species
(25,28) and thus the latent protein is more likely to be formed
by a competing pathway from the unactivated monomer
(Fig. 3 C). The global fitting of the Q curve and three
TCCD histograms for a neuroserpin polymerization at
0.2 mg/mL provided physically meaningful values of theFIGURE 3 Neuroserpin polymeriza-
tion kinetic schemes. Neuroserpin
monomer M is activated to M* with an
activation rate kA; depending on the
model, either a normal (M) or an active
monomer (M*) can undergo a transfor-
mation into the latent form (ML) or
form a dimer M2 by adding either M
or M* that we assume to occur at the
same rate k1; the polymers can grow
by addition of a monomer (M or M*)
with a rate k2, or by addition of an olig-
omer of size i (Mi) with any other olig-
omer of size j to form an oligomer Miþj
at a rate k3 that we assume to be the
same for whatever value of i and j. In
A the latent species is formed from the
activated monomer, M*. In B the dimer
formation and monomer addition only
occur through activated monomers M*;
whereas in C the transformation to non-
polymerizing latent form is a parallel
pathway of the monomer M that may
transform either to the active M* or to
the latent monomer (ML).
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tion quotient time trace and the coinci-
dence histograms to the kinetic model
for neuroserpin polymerization. (A) Ex-
perimental association quotient (symbols)
and the fit (line) for a 0.2 mg/mL neuro-
serpin incubation. (B) Experimental
TCCD histogram after 240 min of incu-
bation and a simulated histogram based
on the global fit (red line). (C) Calculated
distribution of oligomers based on the
kinetic model at the three aliquot times
analyzed: 30 (first bar), 90 (middle bar),
and 240 min (last bar). (D) Experimental
association quotient (symbols) and simu-
lated (lines) using the rate constants in
Table 1 for a 0.1 (circles) and 0.3 mg/
mL (triangles) neuroserpin incubation.
(E) Predicted association quotient time
traces by kinetic model in Fig. 3 C for
neuroserpin polymerization at a total
concentration of 0.1 (dashed), 0.2 (solid),
and 0.3 (dotted) mg/mL.rate constants, with a c2 value of 1.96  103. However,
when the recovered rate constants were used to simulate
the association quotient time traces at other concentrations,
this model predicts very little variation of the plateau with
total monomer concentration, Fig. 4 E. This is in contrast
to our experimental observations. In addition, the model in
Fig. 3 C is a simplification because as the polymers can
form from the folded protein (8,15,25) each monomer
must be activated or partially activated before addition to
the polymer chain, which would lead to unphysical rate
constants as found above. To investigate this further we
then carried out an experiment using gels to see how the frac-
tion of polymers formed in the plateau region varied with the
initial neuroserpin concentration (see the Supporting Mate-
rial). We found more of the neuroserpin formed polymers
when the starting concentration was higher, in contrast to
the predictions of the model in Fig. 3 C. For these reasons
this model was discarded. Thus neuroserpin must polymerize
by a different mechanism where the latent species is formed
from the activated monomer.
Based on the results above the most likely reaction scheme
is that shown in Fig. 3 A. This scheme describes a pathway
that is in good agreement with previous work suggesting
M* is characterized by the opening of s4A and partial loop
insertion (4,8,15,25). Such an intermediate would readily
form either dimers and subsequently polymers, or alterna-
tively the latent species. The global fit of the experimental
curve of Q versus incubation time (Fig. 4 A) and coincident
histograms (Fig. 4 B) at three different incubation times (30,
90, and 240 min) for an incubation of a total neuroserpinconcentration of 0.2 mg/mL (4.4 mM) provided the rate
constant values compiled in Table 1 with a c2 value of
1.94  103. Using these rate constants the concentration
profiles with time of the oligomeric species can be obtained.
Fig. 4 C shows the concentration of oligomeric species up to
hexamers at 30, 90, and 240 min into the incubation. This
figure shows that dimers were predicted to make up the over-
whelming majority of oligomers at both 30 min and 90 min
and represent two-thirds of the oligomeric species in the late-
stage timepoint of 240 min. In addition, the model predicted
very little formation of oligomers larger than 3-mers at all
three timepoints examined. The model also calculated rela-
tively rapid conversion toward latent monomers, predicting
~45% of the monomer converted to a latent form at later
incubation times. The high predicted value for latency rate
was supported by the low association quotient observed
throughout the measurement, and the presence of large
amounts of monomeric species even when the polymeriza-
tion had reached the plateau, as evidenced in the correspond-
ing gels (Fig. 1). Finally, to test the validity of the rate
TABLE 1 Rate constant values for neuroserpin polymerization
at 45C
Activation rate (kA) (7 5 2)  105 s1
Rate of latent
species formation (kL)
0.0295 0.008 s1
Dimer formation (k1) (6 5 1)  103 M1 s1
Growth by monomer
addition (k2)
20 5 10 M1 s1
Growth by polymer
addition (k3)
/ 0Biophysical Journal 97(8) 2306–2315
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were simulated for two other incubation concentrations, 0.1
and 0.3 mg/mL using the rate constants recovered in the
global fit. The theoretical curves showed good agreement
with the experimental values (Fig. 4 D).
It is useful to compare TCCD with gel analysis to follow
neuroserpin polymerization. When carrying out the analysis
of neuroserpin polymerization by gels it is difficult to quan-
tify the amount of each polymer formed. There is the addi-
tional problem that gels are less sensitive and so we cannot
make measurements at early time points. It is for these
reasons that we used the single molecule experiments to
quantify and characterize polymerization. The gels are sensi-
tive to large polymers, however, because they are more
intense in gels. For example, the same amount of 10-mer is
five times more intense than a dimer in a gel. Hence small
populations of large polymers, which will be formed late in
the reaction, can be detected sensitively in the gel. TCCD
is significantly more sensitive to small oligomers and can
be used to study the early stages of the reaction and obtain
quantitative data. However, the encounter rate of the 10-mer
with the probe volume is reduced, due to its smaller diffusion
coefficient compared to a dimer, making TCCD less sensitive
to large oligomers. This is the reason there are fluctuations in
the plateau region in Fig. 2 C because an occasional large
polymer can enter the probe volume and this is not averaged
out over the measurement. In future studies we plan to flow
the sample to eliminate this effect.
Effect of Ab1–40 on neuroserpin polymerization
Having characterized the reaction of neuroserpin alone we
then studied how this was altered by the presence of Ab1–40.
We chose this rather than the more rapidly polymerizing
Ab1–42, to prevent the simultaneous polymerization of both
Ab and neuroserpin, which would have complicated the anal-
ysis. Reaction mixtures containing 0.1 mg/mL (2.2 mM) of
total neuroserpin (0.05 mg/mL of Alexa 488 or Alexa 647-
labeled neuroserpin) were incubated at 45C for 8 h. After
30 min of incubation, different concentrations of unlabeled
Ab1–40 were spiked into the reaction mixture. The time trace
of association quotient showed an enhancement in association
after the addition of Ab1–40 (Fig. 5 A). The additional
enhancement was noted at a molar ratio Ab1–40/Nsp >1:1.
Higher concentrations of Ab1–40 caused further enhancement
of the coincidence levels. Control TCCD measurements on
Ab1–40 alone at the same concentration showed negligible
levels of fluorescence on both the red and blue channels, elim-
inating the possibility that this change in association quotient
was due to fluorescent impurities present in the Ab sample.
The addition of Ab1–40 from the beginning of neuroserpin
incubation also caused an enhancement in the concentration
of oligomeric species (Fig. 5 B). The value of the initial rate
was (10 5 2)  105 s1, an increase by a factor of 1.6
over the rate in the absence of Ab1–40.
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form a complex with Ab that inhibits the formation of
amyloid fibrils, changing the shape of the deposits formed
from fibrils to small spherical aggregates (2). Reciprocally,
Ab is able to irreversibly inactivate neuroserpin for protease
inhibitory activity or polymerization, although this requires
preincubation for at least 30 h at 37C when a 1:1 complex
is formed. We therefore repeated the neuroserpin polymeri-
zation reactions in the presence of Ab1–40 but having previ-
ously preincubated the mixture for 24 h. In contrast to the
experiments in which the Ab1–40 was only added at the start
of the polymerization reaction, no enhancement of the asso-
ciation quotient was detected in these experiments, and the
curves showed similar profiles to those without Ab1–40
(Fig. 5 B).
To determine if there was a complex formed between
Ab1–40 and neuroserpin, at the single molecule level, we pre-
incubated 1:1 molar ratios of Alexa 647-labeled neuroserpin
and HiLyte Fluor 488-labeled Ab1–40, followed by
FIGURE 5 (A) Effect on 0.1 mg/mL neuroserpin polymerization of the
addition of Ab1–40 spiked in after 30 min of incubation (black dotted line).
[Ab1–40]/[Nsp] ¼ 0 (squares), 0.1 (circles), 1 (triangles), 10 (diamonds),
and 100 (inverted triangles). (B) Effect on 0.1 mg/mL neuroserpin polymer-
ization of the addition of equimolar concentration of Ab1–40 at the beginning
of the incubation (open triangles), and preincubation with Ab1–40 for 24 h at
37C (solid circles). Both curves are compared to that obtained in the absence
of Ab1–40 (open squares).
Neuroserpin Polymerization 2313incubation under conditions that would induce neuroserpin
polymerization, and measured different aliquots under
TCCD. The formation of a Nsp/Ab1–40 complex would
give rise to coincident events above background levels.
Indeed, the preincubated mixtures showed the very slow
formation of a 1:1 complex (Fig. 6 A), but always at very
low concentrations. This suggests that either the affinity is
relatively low or that the complex, if formed, is unstable
on dilution to single molecule concentrations. The per-
centage of formed Nsp/Ab1–40 complex was constant during
the neuroserpin polymerization reaction with a value of
0.8 5 0.2% (Q ¼ 0.0016 5 0.0004). Taking into account
the burst rates of the unassociated and associated molecules
and the labeling efficiency we can estimate a dissociation
constant for the Nsp/Ab1–40 complex of 10 5 5 nM (see
the Supporting Material for details), assuming that our
measurements are made at equilibrium. To follow the poly-
merization state of neuroserpin and the effect of the preincu-
bation with Ab1–40, we used a method based on the fact that
neuroserpin oligomers would give rise to brighter fluores-
cence bursts, as TCCD was not applicable in this case
because there was only one fluorophore label on the neuro-
serpin. We therefore calculated the fraction of all fluores-
FIGURE 6 (A) Association quotient for the complex Nsp/Ab1–40 under
preincubation conditions. The solid line indicates the limit of detection of
the TCCD technique. (B) Fraction of Alexa647-Nsp oligomeric events
from Nsp incubations in the presence of HL488-Ab1–40 with (open symbols,
dashed line) and without (solid symbols, solid lines) 24 h of preincubation.cence events due to bright neuroserpin oligomers, with an
intensity values above 175 kHz. Whereas the mixtures
with no preincubation showed an increasing number of neu-
roserpin oligomeric events with incubation time, the preincu-
bated samples did not show a greater number of neuroserpin
oligomers (Fig. 6 B). Although this is less sensitive than the
use of TCCD to probe polymerization, it confirms that prein-
cubation of neuroserpin with Ab1–40 blocks the enhancement
of polymerization.
Neuroserpin alone polymerizes quickly in 4–6 h, whereas
Ab1–40 alone does not progress beyond the very early stages
of fibril formation at a concentration of 2 mM, with significant
aggregation occurring only after 16–17 h (data not shown).
This means that it is very unlikely that the increase in the
rate of neuroserpin polymerization is due to its incorporation
into Ab1–40 fibrils. To confirm this we carried out total internal
reflection fluorescence imaging of the neuroserpin polymers
on a microscope slide and found that the Ab1–40 was not co-
localized with the neuroserpin (see the Supporting Material).
Therefore the increase in polymerization rate of neuroserpin
must be due to an increase in the concentration of activated
monomer as shown in Scheme 1.
Addition of Ab1–40 results in the rapid formation of an
activated intermediate with neuroserpin. This intermediate
is presumably formed by the Ab1–40 peptide inserting into
a partially opened b-sheet A of neuroserpin (2). This species
more rapidly converts into activated monomer and hence
results in both faster polymerization and a higher plateau
of association. When the activated neuroserpin accepts
another monomer, the Ab1–40 is displaced from the complex,
having acted as an effective catalyst of the polymerization. In
contrast, leaving the neuroserpin and Ab1–40 mixture prein-
cubated for 24 h leads to stabilization of the Nsp/Ab1–40
complex, resulting in no additional activated neuroserpin
monomer and no increased rate of polymerization. Neverthe-
less, neuroserpin polymerization occurs under these condi-
tions (Fig. 5 B) because not all neuroserpin molecules form
the stable complex and are thus able to form the active mono-
mer. Both the intermediate and complex are not stable when
diluted down to single molecule level for analysis, hence
only a small fraction of the complex is detectable. This
also explains why we observe no Ab1–40 incorporated into
the growing neuroserpin polymers, and indicates that no neu-
roserpin will be incorporated into the Ab1–40 fibrils. Impor-
tantly the inhibitory effect of neuroserpin in both test tube
experiments and under physiological conditions will depend
on the concentration of both neuroserpin and Ab, along with
the length of time that they have been mixed together. The
SCHEME 1 Scheme for the interaction of Amyloid-b1–40 with neuroser-
pin. A fast transient interaction creates a complex where the neuroserpin
is activated and able to polymerize. If the neuroserpin and Ab1–40 are incu-
bated long enough, they form a stable inactive complex.Biophysical Journal 97(8) 2306–2315
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suggest that the stable complex is the more important
species. This model provides a straightforward way to ex-
plain the observed spherical aggregates that Ab forms in
the presence of neuroserpin (2) because steric repulsion
between the neuroserpin molecules into which the Ab is
inserted (or partially inserted) will cause Ab molecules to
minimize such unfavorable energetic interactions with neu-
roserpin by forming spherical aggregates. This is similar to
surfactants that form spherical micelles as a result of small
tails and large headgroups. The spherical aggregates of Ab
will predictably contain only Ab because its interaction
with neuroserpin is weak and so no neuroserpin is incorpo-
rated into the aggregate.
CONCLUSIONS
We have exploited single molecule fluorescence to study the
polymerization of neuroserpin, and to determine how this is
altered in the presence of Ab1–40. Our data show that neuro-
serpin polymerization occurs by the formation of an active
monomer and that the presence of Ab1–40 increases the
amount of active monomer present, thereby increasing the
rate of polymerization. The insertion of Ab1–40 into the neu-
roserpin b-sheet A facilitates its opening and the interaction
with another neuroserpin monomer, followed by displace-
ment of the Ab1–40 so that it is not ultimately incorporated
into neuroserpin polymers. Therefore, under these conditions
Ab1–40 acts as a catalyst of neuroserpin polymerization.
These experiments are one example of how single molecule
science has advanced to a level where it can start to address
biomedical problems and provide new insights. This trend is
likely to accelerate in the future as the technology matures
and becomes more widely applied.
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